Virtual reality assessment for asylum seekers with paranoid delusions

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the behaviors and threat evaluations of asylum seekers experiencing paranoid delusions through the use of virtual reality (VR). By leveraging VR technology, researchers intend to assess thoughts, behaviors, and emotions in real-time, addressing the challenges posed by language and cultural differences in traditional diagnostic assessments. The study focuses on individuals aged 18 and over who are receiving treatment for psychotic disorders at CTP Veldzicht in the Netherlands. The goal is to evaluate the applicability of VR as a diagnostic tool for this vulnerable population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Aged 18 or over
* Receiving treatment from CTP Veldzicht
* Seeking asylum in the Netherlands, registered with Centraal Opvang Asielzoekers (COA)
* Classification (primary or subsidiary classification) of a disorder categorized within the 'schizophreniaspectrum- and other psychotic disorders' (DSM-V)
* Diagnosed with the symptom of paranoid delusion, defined as a PANSS score on the delusion item (P6) \>2

Exclusion Criteria:

* Unable to provide informed consent
* Acutely psychotic, which means overwhelmed by psychotic symptoms, agitated, not able to participate in an interview, as judged by a therapist or socio-therapist.

Where it's running

• CTP Veldzicht
  Balkbrug, Overijssel, Netherlands Recruiting

Study contacts

• Study coordinator: Ron Haarms, MSc
• Email: r.haarms@umcg.nl
• Phone: 650070910

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Transition Support for First-Episode Psychosis

  A team-based program helps people experiencing their first psychotic episode move from hospital to outpatient care to see if they stay engaged and feel better.

  Recruiting University of Chicago · Chicago, Illinois and 1 other locations · NCT07713849

• SEEG-guided DBS for Schizophrenia

  This study tests whether SEEG-guided deep brain stimulation can help people with treatment-resistant schizophrenia see if symptoms improve.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT07671261

• Using an epigenetic drug to boost virtual reality cognitive training for middle-aged and older adults with depression or bipolar disorder

  This trial will test whether daily sodium butyrate combined with three weeks of virtual reality cognitive training improves thinking skills in symptomatically stable adults aged 40–75 with depression or bipolar disorder.

  Recruiting Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital · Frederiksberg, Capital Region of Denmark · NCT07404085

• Medical and psychiatric profiling of adults admitted to general adult psychiatry wards

  This project will collect questionnaires, rating scales, and case-note information from adults admitted to general adult psychiatry wards to see what their physical and mental health profiles look like.

  Recruiting University of Edinburgh · Livingston, West Lothian · NCT07398365

• iTEST: a blended mobile program to improve introspective accuracy (accurate self-judgment of abilities)

  This trial tests whether iTEST — daily mobile cognitive training plus coaching that focuses on accurate self-judgment — helps adults with schizophrenia-spectrum or other psychotic disorders improve community functioning.

  Recruiting at 3 sites University of California, San Diego · San Diego, California and 2 other locations · NCT07098169

• VR avatar therapy for psychosis: linking thinking, self-awareness, and social cognition

  This project will test whether cognitive, metacognitive, and social-cognition factors relate to how well VR-based avatar therapy helps people with schizophrenia who have persistent auditory hallucinations.

  Recruiting Fundació Sant Joan de Déu · Barcelona, Catalonia · NCT07091344

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.